EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review)

Xiaoying Zhao, Wenjing Zhang, Xiang Yu, Xiaohan Zhao, Xu Dai, Sirui Chen, Yan Wang, Jiang Cheng, Weiwei Zheng

International Journal of Oncology · 2025

DOI: 10.3892/ijo.2025.5836 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2025. Verfasst von Xiaoying Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang Uygur Autonomous Region 832008, P.R. China. Hauptthemen laut MEDLINE: Neoplasms, Epigenesis, Genetic, RNA-Binding Proteins. Die Arbeit nennt 153 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study focused on the role of coiled‑coil domain‑containing protein 137 (CCDC137), an RNA‑binding and epigenetic protein with high expression and poor prognosis in various types of cancer. Bioinformatics analysis, cellular experiments and animal models investigated the functions of CCDC137 in RNA post‑transcriptional regulation, epigenetic modification and the tumor microenvironment. The results showed that CCDC137 can bind specific mRNAs to affect physiological processes such as the cell cycle, participate in epigenetic regulation such as DNA methylation and histone modification and influence tumor immune escape by affecting the functions of tumor‑associated macrophages. Based on the multidimensional regulatory functions of CCDC137, it is expected to become a new target for cancer diagnosis and treatment and provide a theoretical basis for precision cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsEpigenesis, GeneticRNA-Binding ProteinsHumansGene Expression Regulation, NeoplasticAnimalsTumor MicroenvironmentDNA MethylationRNA, Messenger

Stichwörter der Autor:innen

CCDC137RNA binding proteinscycleepigenetictumor microenvironment

Substanzen

RNA-Binding ProteinsRNA, Messenger

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang Uygur Autonomous Region 832008, P.R. China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China.
  • First School of Clinical Medicine, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
  • School of Clinical Medicine, Xinjiang Second Medical College, Karamay, Xinjiang Uygur Autonomous Region 834000, P.R. China.
  • School of Laboratory Medicine, Bengbu Medical University, Bengbu, Anhui 233030, P.R. China.
  • Department of Laboratory Medicine, Wenjiang District People's Hospital of Chengdu, Chengdu, Sichuan 611100, P.R. China.

Zitieren

APA

Zhao, X., Zhang, W., Yu, X., Zhao, X., Dai, X., Chen, S., Wang, Y., Cheng, J., & Zheng, W. (2025). CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2025.5836

Vancouver

Zhao X, Zhang W, Yu X, Zhao X, Dai X, Chen S, et al. CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review). International Journal of Oncology. 2025. doi:10.3892/ijo.2025.5836

BibTeX
@article{Zhao2025,
  author = {Zhao, Xiaoying and Zhang, Wenjing and Yu, Xiang and Zhao, Xiaohan and Dai, Xu and Chen, Sirui and Wang, Yan and Cheng, Jiang and Zheng, Weiwei},
  title = {CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review)},
  journal = {International Journal of Oncology},
  year = {2025},
  doi = {10.3892/ijo.2025.5836}
}
Kostenlos starten →